Congenital defects of phagocyte number, function, or both

Congenital defects of phagocyte number, function, or both are a group of rare immunodeficiency disorders where the body's ability to fight infections is impaired due to issues with phagocytes, a type of white blood cells that engulf and digest bacteria and fungi. These conditions can lead to increased susceptibility to infections and can affect individuals from birth.

Overview

Phagocytes, primarily neutrophils, monocytes, and macrophages, play a crucial role in the body's innate immune response by identifying, engulfing, and destroying pathogens. Congenital defects in these cells can be due to either a reduced number of phagocytes, known as quantitative defects, or abnormalities in phagocyte function, known as qualitative defects. In some cases, patients may have a combination of both.

Types of Congenital Phagocyte Defects

Quantitative Defects

• Chronic Granulomatous Disease (CGD): A condition characterized by a defect in the NADPH oxidase complex, leading to reduced production of reactive oxygen species (ROS) necessary for killing bacteria and fungi.
• Severe Congenital Neutropenia (SCN): Marked by a significant decrease in the number of circulating neutrophils, making individuals highly susceptible to bacterial infections.
• Leukocyte Adhesion Deficiency (LAD): A disorder affecting the migration of leukocytes from the blood into tissues, resulting in recurrent bacterial infections without pus formation.

Qualitative Defects

• Myeloperoxidase Deficiency: The most common phagocyte defect, characterized by the absence or reduced activity of myeloperoxidase, an enzyme in neutrophils that helps kill certain organisms.
• Glucose-6-phosphate dehydrogenase (G6PD) Deficiency: A condition affecting the G6PD enzyme, which is important for the health of all cells, including phagocytes. Its deficiency can lead to hemolytic anemia and increased susceptibility to infections.

Diagnosis

Diagnosis of congenital defects of phagocyte number, function, or both involves a combination of clinical evaluation, family history, and specialized laboratory tests. These tests can include complete blood counts (CBC) with differential, flow cytometry for specific markers, and assays to evaluate phagocyte function, such as the nitroblue tetrazolium (NBT) test or the dihydrorhodamine (DHR) flow cytometry test for CGD.

Treatment

Treatment strategies for congenital phagocyte defects vary depending on the specific disorder and its severity. They may include:

• Antibiotics and antifungal medications to prevent or treat infections.
• Granulocyte Colony-Stimulating Factor (G-CSF): Used in conditions like SCN to increase neutrophil production.
• Hematopoietic Stem Cell Transplantation (HSCT): Considered for severe cases, especially when other treatments have failed.
• Gene therapy: An emerging treatment option for some types of congenital phagocyte defects, such as CGD.

Prognosis

The prognosis for individuals with congenital defects of phagocyte number, function, or both varies widely depending on the type and severity of the defect, as well as the effectiveness of the treatment regimen. Early diagnosis and appropriate management are crucial for improving outcomes and quality of life.

‎

---

Translate: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian